Agentic AI Enters the Clinic

The term agentic AI refers to artificial intelligence systems that not only answer questions but also perform tasks autonomously — for example, searching databases, routing queries to the right experts, or organizing workflows. In Mirxes' case, it is an assistant that gives doctors instant access to verified medical knowledge, scientific studies, and the company's internal documentation.

According to a report by iTnews Asia, the system processes scientific and product queries almost in real time. "Early cancer detection depends on the accuracy, speed, and trust in the information clinicians receive," said Dr. Zhou Lihan of Mirxes. "By providing rapid access to precise and up-to-date information, we can reduce their burden and allow them to focus more on direct patient care and clinical decision-making."

This means that a doctor no longer has to sift through dozens of pages of medical literature or wait for a response from a specialist inside the company. The assistant finds and delivers relevant information within seconds.

How the Technology Actually Works

The new assistant is powered by a combination of several advanced technologies. The foundation is the Oracle AI Database and Oracle Cloud Infrastructure (OCI) Enterprise AI, which enable processing of large volumes of structured and unstructured data. The system draws on carefully selected medical literature, scientific research, and the company's internal documentation.

A key role is played by the Retrieval-Augmented Generation (RAG) technique. Simply explained: instead of the AI generating answers solely based on what it learned during training, it first searches for relevant information in verified sources and only then composes a response. This significantly reduces the risk of so-called hallucinations, where the AI invents false information.

It is complemented by semantic search. While traditional search engines look for exact words, semantic search understands the meaning of a query. A doctor therefore does not have to struggle with the correct formulation of a technical term — the system understands the context and finds matching information even when using more common language.

Autonomous Capabilities Without Loss of Control

What makes this system "agentic" is its ability to independently route product queries and feedback to the appropriate teams within the company. If a doctor asks a question the assistant cannot answer directly, or if it identifies a potential issue, the system automatically passes it on to the correct department.

It is important to emphasize that clinical decisions remain fully in the hands of healthcare professionals. The assistant functions as a support tool; it does not replace medical judgment. The system is designed to comply with regulatory requirements and personal data protection standards, which is critical in medicine.

Who Is Mirxes and Why It Matters

Mirxes is a Singapore-based biotech company founded in 2014, specializing in RNA-based diagnostics in the Asia-Pacific region. Its flagship product is GASTROClear — a groundbreaking blood test for early detection of gastric cancer. In August 2023, this test received FDA Breakthrough Device designation from the U.S. Food and Drug Administration, and in October 2025 it was approved by China's NMPA.

In May 2025, the company became the first biotech unicorn in Southeast Asia following its debut on the Hong Kong Stock Exchange (HKEX). In January 2025, it also announced $40 million in funding from the CBC Group to accelerate global expansion. The new AI assistant is therefore part of a broader strategy to streamline support for clinicians in deploying advanced diagnostic tools.

What This Means for the Czech Republic and Europe

While Mirxes operates primarily in Asia, the principles it is introducing are globally relevant. Czech healthcare and the European system as a whole face similar challenges: overworked doctors, the complexity of medical information, and the need for faster diagnosis. Agentic AI assistants could help Czech oncologists and general practitioners navigate new findings and procedures more quickly.

At the same time, Europe is grappling with stricter regulatory requirements. The European Artificial Intelligence Act (EU AI Act) classifies systems used in healthcare as high-risk, which means they must meet strict standards of transparency, safety, and oversight of decision-making. Every AI tool deployed in a Czech hospital or clinic will have to undergo rigorous conformity assessment.

From a Czech perspective, it is also important to note that there is not yet any mass deployment of similar agentic systems in Czech healthcare facilities. Some hospitals are experimenting with AI for analysis of imaging data or administrative tasks, but a full-fledged clinical assistant with autonomous capabilities remains largely in the pilot project stage — much like at Mirxes.

When Will We See Similar Tools in Everyday Practice

Mirxes explicitly states that this is not a massive overhaul of the entire healthcare system using AI, but rather targeted deployment for a specific use case — improving knowledge delivery in environments where speed and accuracy are critical. This approach is more realistic and likely to succeed than attempts at immediate "AI transformation" of the entire sector.

For ordinary patients, this means that if their doctor uses a similar tool, they can receive more accurate information more quickly — especially in time-sensitive situations such as early detection of cancer. For Czech healthcare, this raises the question of how quickly and safely it can adapt similar innovations while considering local regulations and language specifics.

Frequently Asked Questions